Table 2.
Unadjusted and adjusted hazard ratios for factors related to initiation of prescription opioid injection among people who use drugs in Vancouver (n= 1580).
| Variable | Hazard Ratio (95% CI)* | |||
|---|---|---|---|---|
|
|
||||
| Unadjusted | p-value | Adjusted | p-value | |
| Sex (Female vs. Male) | 1.11 (0.86–1.44) | 0.421 | ||
| Age (Per year older) | 1.00 (0.99–1.01) | 0.654 | ||
| Ethnicity (Caucasian vs. Non-Caucasian) | 1.51 (1.16–1.96) | 0.002 | 1.37 (1.04–1.79) | 0.024 |
| Education (≥ Sec. vs. < Sec.) | 1.38 (1.07–1.77) | 0.012 | 1.44 (1.12–1.87) | 0.005 |
| Follow-up Period (per 6-month interview interval) | 0.95 (0.91–0.99) | 0.008 | 0.97 (0.93–1.00) | 0.063 |
| Cohort | ||||
| ACCESS (vs. ARYS) | 1.26 (0.88–1.79) | 0.207 | ||
| VIDUS (vs. ARYS) | 1.73 (1.25–2.40) | <0.001 | ||
| Downtown Eastside Residency** | 1.85 (1.42–2.40) | <0.001 | 1.31 (1.00–1.71) | 0.047 |
| Homelessness** | 1.19 (0.91–1.56) | 0.213 | ||
| Incarcerated** | 1.29 (0.91–1.84) | 0.158 | ||
| Addiction Treatment Enrolment** | ||||
| Non-methadone treatment (vs. none) | 1.20 (0.80–1.81) | 0.383 | 1.16 (0.76–1.75) | 0.498 |
| Methadone treatment (vs. none) | 4.46 (2.03–9.80) | <0.001 | 2.96 (1.34–6.51) | 0.007 |
| Methadone and non-methadone (vs. none) | 2.45 (1.85–3.24) | <0.001 | 1.37 (1.03–1.82) | 0.031 |
| Drug Dealing** | 1.76 (1.34–2.31) | <0.001 | 1.32 (1.00–1.76) | 0.050 |
| Sex work** | 1.05 (0.68–1.64) | 0.824 | ||
| Heavy Alcohol Use** | 0.78 (0.57–1.07) | 0.121 | ||
| Heroin Injection** | 6.30 (4.83–8.20) | <0.001 | 4.39 (3.24–5.95) | <0.001 |
| Heroin Non-injection** | 1.54 (1.06–2.23) | 0.023 | ||
| Cocaine Injection** | 2.23 (1.71–2.89) | <0.001 | 1.40 (1.06–1.84) | 0.018 |
| Crack/coc. Non-injection** | 1.69 (1.25–2.28) | <0.001 | ||
| Methamphetamine Injection** | 2.16 (1.56–3.00) | <0.001 | 1.71 (1.22–2.39) | 0.002 |
| Methamphetamine Non-injection** | 0.91 (0.64–1.30) | 0.619 | ||
| Prescription Opioid Non-injection** | 1.94 (1.22–3.09) | 0.005 | 1.99 (1.25–3.17) | 0.004 |
| Marijuana Use** | 1.04 (0.80–1.35) | 0.773 | ||
| Sexual Abuse** | 1.12 (0.84–1.49) | 0.441 | ||
| Suicide Attempt** | 1.56 (0.85–2.87) | 0.150 | ||
95% Confidence Interval.
In the previous six months (yes vs. no), lagged to the previous follow-up to prescription opioid injection initiation assessment.